Based on this, this study explored whether FCGR2B could regulate hippocampal neuronal excitability by regulating the expression of SHC1 and PI3K/AKT signaling pathway, thereby participating in cognitive dysfunction in DM. This evidence concerns the gene AKT1 and diabetes mellitus.